SOX2 and lung cancer: Another supporting study showed that TRPM7 overexpression resulted in the increased expression of cancer stemness markers such as SOX2, KLF4, and CD133 in lung cancer, while TRPM7-silencing led to the reduction of stemness and EMT traits [34, 35].